GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
Phenylephrine:CVS pulls cold medicines with the ingredient Companies such as Procter & Gamble and GSK were among several accused in lawsuits of deceiving consumers about cold medicines containing the ...
There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...
WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...
When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...
"The launch of the DREAM completes our vision of the Lupus Nexus," said Devon Kelly, Director, Lupus Nexus, Lupus Research ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will share new data from its industry-leading HIV treatment and prevention portfolio ...
Johnson & Johnson announced at its booth the China market launch of INVEGA HAFYERA, a medicine for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback